今年传染病临床科学领域的热点话题。
What's Hot This Year in Infectious Diseases Clinical Science.
作者信息
Freiberg Jeffrey A, Wright Patty W
机构信息
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
出版信息
Clin Infect Dis. 2025 Jul 18;80(6):1216-1220. doi: 10.1093/cid/ciaf037.
Abstract
Clinical science in the field of infectious diseases (ID) moved at a rapid pace in 2024. Among the highlights were multiple trials of new antibiotics and new approaches to prevent infections. Concerning trends, with outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A in 2024, demonstrate the importance of ID and the continued need for further advances through clinical science. This review highlights some of the most important trials and clinical trends in ID over the past year.
摘要
2024年，传染病领域的临床科学发展迅速。其中的亮点包括多项新型抗生素试验以及预防感染的新方法。关于趋势，2024年登革热、麻疹、猴痘和高致病性甲型禽流感的爆发，彰显了传染病学的重要性以及通过临床科学持续取得进一步进展的必要性。本综述重点介绍了过去一年传染病领域一些最重要的试验和临床趋势。
相似文献
1
What's Hot This Year in Infectious Diseases Clinical Science.今年传染病临床科学领域的热点话题。
Clin Infect Dis. 2025 Jul 18;80(6):1216-1220. doi: 10.1093/cid/ciaf037.
2
Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model.用于减少抗菌药物耐药性的尿路感染即时检测：一项系统评价和概念性经济模型
Health Technol Assess. 2024 Nov;28(77):1-109. doi: 10.3310/PTMV8524.
3
Probiotics for preventing acute upper respiratory tract infections.益生菌预防急性上呼吸道感染。
Cochrane Database Syst Rev. 2022 Aug 24;8(8):CD006895. doi: 10.1002/14651858.CD006895.pub4.
4
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study.刚果民主共和国金沙萨两起不同的猴痘疫情的流行病学和系统基因组特征分析，涉及一个新的Ia亚分支谱系：一项回顾性观察研究
Lancet. 2025 Jul 5;406(10498):63-75. doi: 10.1016/S0140-6736(25)00294-6.
5
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
6
Psychological interventions for adults who have sexually offended or are at risk of offending.针对有性犯罪行为或有性犯罪风险的成年人的心理干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007507. doi: 10.1002/14651858.CD007507.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗：一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病（COPD）的预防性抗生素治疗
Cochrane Database Syst Rev. 2013 Nov 28(11):CD009764. doi: 10.1002/14651858.CD009764.pub2.
10
Local anti-infective therapy: pharmacological agents. A systematic review.局部抗感染治疗：药物制剂。一项系统评价
Ann Periodontol. 2003 Dec;8(1):79-98. doi: 10.1902/annals.2003.8.1.79.
本文引用的文献
1
Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers - Michigan and Colorado, June-August 2024.血清学证据显示，密歇根州和科罗拉多州的乳品工人近期感染了高致病性禽流感病毒（H5）。
MMWR Morb Mortal Wkly Rep. 2024 Nov 7;73(44):1004-1009. doi: 10.15585/mmwr.mm7344a3.
2
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.猴痘临床特征、诊断方法及治疗策略：综述。
JAMA. 2024 Nov 19;332(19):1652-1662. doi: 10.1001/jama.2024.21091.
3
WHO Director-General declares mpox outbreak a public health emergency of international concern.世界卫生组织总干事宣布猴痘疫情构成“国际关注的突发公共卫生事件”。
Saudi Med J. 2024 Aug;45(9):1002-1003.
4
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.奈玛特韦/利托那韦口服作为新冠病毒暴露后预防。
N Engl J Med. 2024 Jul 18;391(3):224-234. doi: 10.1056/NEJMoa2309002.
5
Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial.在初级保健中，鼻喷雾剂和行为干预与常规护理治疗急性呼吸道疾病的比较：一项随机、对照、开放标签、平行组试验。
Lancet Respir Med. 2024 Aug;12(8):619-632. doi: 10.1016/S2213-2600(24)00140-1. Epub 2024 Jul 11.
6
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.头孢吡肟-他唑巴坦治疗复杂性尿路感染。
N Engl J Med. 2024 Feb 15;390(7):611-622. doi: 10.1056/NEJMoa2304748.
7
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials.口服 gepotidacin 与硝基呋喃妥因治疗单纯性尿路感染患者（EAGLE-2 和 EAGLE-3）：两项随机、对照、双盲、双模拟、3 期、非劣效性试验。
Lancet. 2024 Feb 24;403(10428):741-755. doi: 10.1016/S0140-6736(23)02196-7. Epub 2024 Feb 8.
8
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.利迪尼唑与万古霉素治疗艰难梭菌感染的随机、双盲、3期安全性和有效性研究：微生物组和代谢组与反应相关性的临床结果
Clin Infect Dis. 2024 Jun 14;78(6):1462-1472. doi: 10.1093/cid/ciad792.
9
Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial.头孢曲松预防急性脑损伤患者早期呼吸机相关性肺炎：一项多中心、随机、双盲、安慰剂对照、评估者设盲的优效性试验。
Lancet Respir Med. 2024 May;12(5):375-385. doi: 10.1016/S2213-2600(23)00471-X. Epub 2024 Jan 20.
10
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.早期口服切换治疗低危金黄色葡萄球菌血流感染（SABATO）的疗效和安全性：一项国际、开放标签、平行组、随机、对照、非劣效性试验。
Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17.
Zotero 插件